News
AstraZeneca Claims Research Success In Early Lung Cancer
The most prevalent kind of the disease, non-small cell lung cancer, has seen steady advancements in immunotherapies called checkpoint inhibitors during the past ten years. First, medications like Keytruda from Merck & Co., Opdivo from Bristol-Myers Squibb, and Tecentriq...
News
The Importance of Business Language Training in the Pharma Sector
While corporate language training and business language courses are vastly important for any sector of business, it has become increasingly clear that it is even more important for the pharma sector. The globalization of the pharma industry means that...
News
What is Migraine, and Why Do Some People Have It?
People without migraines would not know how painful an episode could be. Many people can get bad headaches during their lifetime, but migraine is not in that class. A migraine is different, characterised by an intense headache with nausea,...
News
The Rise of Dermal Fillers for Treating Under-Eye Shadows
The eyes are one part of the face that tends to show age the most. Over time, fine lines start to appear in the corners and there might be noticeable shadows or ‘bags’ under the lower eyelids, which can...
News
Amref, Astrazeneca Build COVID-19 Mobile Clinics In Kenya
In an effort to shield last-mile communities from the pandemic, Amref Health Africa and AstraZeneca are introducing a fleet of Mobile Vaccination Clinics (MVCs) in partnership with the Ministry of Health (MoH) in Kenya. The ten mobile clinics will target...
News
US FDA Advisers Advocate Changing Fall COVID Vaccine Dosage
To address more recently circulating coronavirus strains, advisors to the U.S. Food and Drug Administration recently suggested altering the design of COVID-19 booster doses this fall. The next round of COVID booster shots should contain a component that combats the...
News
Novartis Will Cut 8,000 Jobs By 2024 To Save $1 Billion
As many as 8,000 employees could be eliminated by Novartis AG as part of a plan to improve the pharmaceutical behemoth's performance and save at least $1 billion by 2024. The Swiss company announced the restructure in April and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read